ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SPRB vs BGM // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Spruce Biosciences Inc. (NASDAQ) VS. BGM Group Ltd. (Class A) (NASDAQ) • 15-METRIC TALLY: SPRB 2 — BGM 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SPRB VS. BGM) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SPRB BGM SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 16.60% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% — — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -24.77% -3.09% -21.68 BGM /fcf-yield <GO>
Operating Margin — -33.20% — TIE /operating-margins <GO>
Net Profit Margin — -52.60% — TIE /net-margins <GO>
Revenue Growth (YoY) — 51.10% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 2/9 +2.00 SPRB /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 52.1 56.6 -4.50 BGM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $133.3M $127.4M $5.9M SPRB /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SPRB REV BGM REV SPRB GROSS % BGM GROSS % SPRB FCF BGM FCF
FY 2025 $0 $37.9M — 16.6% -$33.3M -$3.9M
FY 2024 $4.9M $25.1M — 16.4% -$56.0M $304.1K
FY 2023 $10.1M $46.5M — — -$33.3M $312.2K
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SPRB // BETA —
BGM // BETA —